Tuberculous Meningitis Treatment Global Market Report 2025
상품코드:1769780
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 결핵성 수막염 치료 시장 규모는 향후 수년간 급성장이 예상됩니다. 예측 기간 중에 예상되는 현저한 동향으로는 디지털 헬스 솔루션이나 원격 의료의 채용, 새로운 항결핵약이나 지지 요법의 출현, HIV 치료 프로그램에의 TBM 치료의 통합, 보다 신속하고 정확한 결과를 얻기 위한 진단 기술의 개선, 병용 치료 전략의 혁신 등을 들 수 있습니다.
수막염의 유병률 증가는 결핵성 수막염 치료 시장의 성장을 이끌 것으로 예측됩니다. 2024년 9월, Meningitis Now는 2023년에 확인된 침습성 수막염균 감염증의 증례는 396건으로, 2022년 205건보다 증가하고 있다고 보고했습니다. 그 결과, 수막염의 유병률의 상승이, 결핵성 수막염 치료제 수요를 부추고 있습니다.
결핵성 수막염 치료 시장의 성장은 헬스케어 지출 증가에 의해서도 지원되고 있습니다. 고령자는 일반적으로 더 많은 의료 서비스, 장기 관리, 노화 관련 질병의 치료가 필요하기 때문에 건강 관리 시스템에 추가적인 부담을 가할 것입니다. 의료비 증가는 더 좋은 진단, 첨단 약물요법, 전문적인 케어, 연구 개발을 가능하게 함으로써 결핵성 수막염의 치료를 지원하고, 이들 모두가 환자의 결과 개선에 기여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 결핵성 수막염 치료 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 결핵성 수막염 치료 시장 : 성장률 분석
세계의 결핵성 수막염 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 결핵성 수막염 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 결핵성 수막염 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 결핵성 수막염 치료 시장 : 치료별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
항생제 요법
보조 코르티코스테로이드 요법
뇌신경외과 관리
세계의 결핵성 수막염 치료 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 결핵성 수막염 치료 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
전문 클리닉
기타 최종 사용자
세계의 결핵성 수막염 치료 시장 : 항생제 요법 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제1선택 항결핵제
제2선택 항결핵제
세계의 결핵성 수막염 치료 시장 : 보조적 코르티코스테로이드 요법 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
덱사메타손
프레드니솔론
세계의 결핵성 수막염 치료 시장 : 뇌신경외과 관리 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
뇌실 복강 션트
뇌실 배수(EVD)
결핵종 수술 절제
제7장 지역별/국가별 분석
세계의 결핵성 수막염 치료 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 결핵성 수막염 치료 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
결핵성 수막염 치료 시장 : 경쟁 구도
결핵성 수막염 치료 시장 : 기업 프로파일
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Otsuka Pharmaceutical Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sun Pharmaceutical Industries Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Aurobindo Pharma Limited
Cipla Limited
Cadila Pharmaceuticals Ltd.
Amneal Pharmaceuticals Inc.
Lupin Limited
Alkem Laboratories Limited
Macleods Pharmaceuticals Ltd.
Torrent Pharmaceuticals Limited
Strides Pharma Science Limited
Ajanta Pharma Limited
Wockhardt Limited
Orchid Pharma Limited
Panacea Biotec Limited
Anuh Pharma Ltd.
Rusan Pharma Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
결핵성 수막염 치료 시장(2029년) : 새로운 기회를 제공하는 국가
결핵성 수막염 치료 시장(2029년) : 새로운 기회를 제공하는 부문
결핵성 수막염 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Tuberculous meningitis treatment refers to the medical approach utilized to manage meningitis caused by the infection of Mycobacterium tuberculosis in the membranes that encase the brain and spinal cord. This treatment generally requires a long-term regimen involving multiple anti-tuberculosis medications, along with supportive therapies and, in some cases, corticosteroids to minimize inflammation and mitigate complications.
The primary treatment modalities for tuberculous meningitis include antibiotic therapy, adjunctive corticosteroid therapy, and neurosurgical interventions. Antibiotic therapy involves the administration of drugs that either eliminate or inhibit the growth of bacteria responsible for the infection. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to various end users such as hospitals, specialty clinics, and other healthcare facilities.
The tuberculous meningitis treatment market size has grown rapidly in recent years. It will grow from $169.67 billion in 2024 to $187.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. This growth during the historical period can be attributed to the widespread prevalence of tuberculosis, the surge in HIV/AIDS cases, supportive governmental measures to combat TB, heightened awareness among healthcare professionals, and deficiencies in medical infrastructure.
The tuberculous meningitis treatment market size is expected to see rapid growth in the next few years. It will grow to $279.39 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The projected growth is driven by the increasing occurrence of drug-resistant and extensively drug-resistant forms of TBM, advancements in pediatric formulations, increased funding from governments and international health organizations, and expanding efforts in public education and early detection. Prominent trends anticipated in the forecast period include the adoption of digital health solutions and telemedicine, emergence of new anti-TB medications and supportive therapies, integration of TBM care with HIV treatment programs, improvements in diagnostic technologies for quicker and more accurate results, and innovations in combination treatment strategies.
The increasing prevalence of meningitis is expected to drive the growth of the tuberculous meningitis treatment market. Meningitis, an inflammation of the protective membranes surrounding the brain and spinal cord, is typically caused by infections and can result in severe neurological complications requiring immediate medical care. Antimicrobial resistance is contributing to the rising prevalence of meningitis, making bacterial infections harder to treat, which leads to prolonged illness, higher transmission rates, and an elevated risk of outbreaks. Tuberculous meningitis treatment plays a critical role in managing the disease by eradicating tuberculosis bacteria, reducing inflammation in the brain, and relieving intracranial pressure to prevent complications and support patient recovery. For example, in September 2024, Meningitis Now, a UK-based meningitis charity, reported 396 confirmed cases of invasive meningococcal disease in 2023, an increase from 205 cases in 2022. As a result, the rising prevalence of meningitis is fueling the demand for tuberculous meningitis treatments.
The growth of the tuberculous meningitis treatment market is also supported by increasing healthcare expenditure. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related resources within a specific timeframe. The aging global population is a major factor driving higher healthcare costs, as older individuals typically require more medical services, long-term care, and treatments for age-related conditions, putting added pressure on healthcare systems. Increased healthcare spending supports the treatment of tuberculous meningitis by enabling better diagnostics, advanced drug therapies, professional care, and research and development, all of which contribute to improved patient outcomes. For instance, in April 2025, the American Medical Association reported that healthcare spending in the U.S. grew by 7.5% in 2023, reaching $4.9 trillion or $14,570 per person, which is a notable rise compared to the 4.6% increase recorded in 2022. This growing investment in healthcare is enhancing the development and accessibility of tuberculous meningitis treatments.
Leading companies in the tuberculous meningitis treatment market are focusing on advancing therapeutic options through clinical trials to improve treatment efficacy and patient outcomes. Clinical trials are research studies conducted on humans to determine the safety, effectiveness, and optimal use of medical treatments such as drugs, vaccines, or procedures. These studies are vital for assessing how new treatments perform, identifying potential side effects, and comparing them to existing options before they are approved for broader use. For instance, in December 2023, the AIDS Clinical Trials Group, a U.S.-based organization specializing in HIV clinical research, initiated the IMAGINE-TBM (A5384) clinical trial. This international, randomized, open-label phase 2 study is testing a new six-month treatment regimen for tuberculous meningitis consisting of high-dose rifampicin, high-dose isoniazid, linezolid, and pyrazinamide. The new regimen is being compared to the current standard nine-month therapy. The trial, involving 330 participants aged 15 and older from several high-TB-burden countries, aims to assess the safety and effectiveness of the shorter regimen to improve outcomes and reduce the duration of treatment for this serious condition.
Asia-Pacific was the largest region in the tuberculous meningitis treatment market in 2024. The regions covered in tuberculous meningitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tuberculous meningitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tuberculous meningitis treatment market includes revenues earned by entities by providing services such as, intravenous fluid management, nutritional support, hospitalization and critical care, management of intracranial pressure, and follow-up and rehabilitation services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tuberculous Meningitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tuberculous meningitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tuberculous meningitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tuberculous meningitis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Tuberculous Meningitis Treatment Market Trends And Strategies
4. Tuberculous Meningitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Tuberculous Meningitis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Tuberculous Meningitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tuberculous Meningitis Treatment Market Growth Rate Analysis
5.4. Global Tuberculous Meningitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tuberculous Meningitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tuberculous Meningitis Treatment Total Addressable Market (TAM)
6.1. Global Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotic Therapy
Adjunctive Corticosteroid Therapy
Neurosurgical Management
6.2. Global Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.3. Global Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End Users
6.4. Global Tuberculous Meningitis Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs
6.5. Global Tuberculous Meningitis Treatment Market, Sub-Segmentation Of Adjunctive Corticosteroid Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dexamethasone
Prednisolone
6.6. Global Tuberculous Meningitis Treatment Market, Sub-Segmentation Of Neurosurgical Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ventriculoperitoneal Shunt
External Ventricular Drainage (EVD)
Surgical Removal Of Tuberculoma
7. Tuberculous Meningitis Treatment Market Regional And Country Analysis
7.1. Global Tuberculous Meningitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tuberculous Meningitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tuberculous Meningitis Treatment Market
9.1. China Tuberculous Meningitis Treatment Market Overview
9.2. China Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tuberculous Meningitis Treatment Market
10.1. India Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tuberculous Meningitis Treatment Market
11.1. Japan Tuberculous Meningitis Treatment Market Overview
11.2. Japan Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tuberculous Meningitis Treatment Market
12.1. Australia Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tuberculous Meningitis Treatment Market
13.1. Indonesia Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tuberculous Meningitis Treatment Market
14.1. South Korea Tuberculous Meningitis Treatment Market Overview
14.2. South Korea Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tuberculous Meningitis Treatment Market
15.1. Western Europe Tuberculous Meningitis Treatment Market Overview
15.2. Western Europe Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tuberculous Meningitis Treatment Market
16.1. UK Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tuberculous Meningitis Treatment Market
18.1. France Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tuberculous Meningitis Treatment Market
19.1. Italy Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tuberculous Meningitis Treatment Market
20.1. Spain Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tuberculous Meningitis Treatment Market
21.1. Eastern Europe Tuberculous Meningitis Treatment Market Overview
21.2. Eastern Europe Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tuberculous Meningitis Treatment Market
22.1. Russia Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tuberculous Meningitis Treatment Market
23.1. North America Tuberculous Meningitis Treatment Market Overview
23.2. North America Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tuberculous Meningitis Treatment Market
24.1. USA Tuberculous Meningitis Treatment Market Overview
24.2. USA Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tuberculous Meningitis Treatment Market
26.1. South America Tuberculous Meningitis Treatment Market Overview
26.2. South America Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tuberculous Meningitis Treatment Market
27.1. Brazil Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tuberculous Meningitis Treatment Market
28.1. Middle East Tuberculous Meningitis Treatment Market Overview
28.2. Middle East Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tuberculous Meningitis Treatment Market
29.1. Africa Tuberculous Meningitis Treatment Market Overview
29.2. Africa Tuberculous Meningitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tuberculous Meningitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tuberculous Meningitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tuberculous Meningitis Treatment Market Competitive Landscape And Company Profiles
